It's an upgrade worth making, but it comes down to your privacy concerns.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...

OpenAI and Broadcom unveiled Jalapeño, a custom AI inference chip designed in nine months. Early tests show 50% cost savings over standard GPUs, with deployment planned for late 2026.

Recently, the concept of so-called covenants has received renewed attention as Bitcoin development and protocol discussions underwent a renaissance. Covenants could enable and facilitate a wide range ...

Most coverage treats “the Palantir Mafia” as a cute analogy — a nod to the PayPal Mafia that gave us Tesla, LinkedIn, YouTube and Yelp. That framing undersells it. The Palantir Mafia is not analogous ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The company, along with others, is pursuing a new paradigm for cramming more transistors on chips—building up.